Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
73.81
+1.14 (1.57%)
Nov 21, 2024, 4:00 PM EST - Market closed
Insmed Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Insmed stock have an average target of 83.64, with a low estimate of 42 and a high estimate of 105. The average target predicts an increase of 13.32% from the current stock price of 73.81.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Reiterates $100 → $105 | Strong Buy | Reiterates | $100 → $105 | +42.26% | Nov 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +21.93% | Nov 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $85 → $100 | Strong Buy | Maintains | $85 → $100 | +35.48% | Oct 11, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $84 → $86 | Strong Buy | Maintains | $84 → $86 | +16.52% | Oct 9, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $72 → $74 | Buy | Maintains | $72 → $74 | +0.26% | Oct 3, 2024 |
Financial Forecast
Revenue This Year
363.07M
from 305.21M
Increased by 18.96%
Revenue Next Year
515.43M
from 363.07M
Increased by 41.96%
EPS This Year
-5.52
from -5.34
EPS Next Year
-4.32
from -5.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 379.8M | 679.7M | 1.5B | ||
| Avg | 363.1M | 515.4M | 1.1B | ||
| Low | 344.0M | 396.9M | 616.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 24.4% | 87.2% | 193.9% | ||
| Avg | 19.0% | 42.0% | 106.8% | ||
| Low | 12.7% | 9.3% | 19.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.41 | -3.28 | -0.76 | ||
| Avg | -5.52 | -4.32 | -2.32 | ||
| Low | -5.57 | -4.83 | -3.42 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.